Marianne de Visser

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

Michael A. van Es, Jan H. Veldink, Christiaan G. J. Saris et al. · Nature Genetics · 2009 · 402 citations

Genome-wide Association Study, Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis +7

Evidence for an oligogenic basis of amyotrophic lateral sclerosis

Marka van Blitterswijk, Michael A. van Es, Eric A. M. Hennekam et al. · Human Molecular Genetics · 2012 · 344 citations · Full text

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

Geert Jan Groeneveld, Jan H. Veldink, Ingeborg van der Tweel et al. · Annals of Neurology · 2003 · 283 citations

NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

Kevin P. Kenna, Perry T.C. van Doormaal, Annelot M. Dekker et al. · Nature Genetics · 2016 · 278 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +4